---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-007111"
form_type: "8-K"
ticker: "BRGX"
cik: "0001593184"
company_name: "BIOREGENX, INC."
filed_at: "2024-10-11T23:59:59+00:00"
generated_at: "2026-05-30T15:26:36.733762+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# BioRegenx appoints Richard Janney to board; forms audit committee

## Summary
- Richard Janney appointed to BioRegenx board effective October 7, 2024, until successor elected or removed.
- Board formed an audit committee; Janney and existing director Suzanne Bird named as members.
- No material plan, contract, or arrangement exists between Janney and BioRegenx; no proposed transactions.

## SEC filing metadata
- accession: 0001683168-24-007111
- form_type: 8-K
- ticker: BRGX
- cik: 0001593184
- company_name: BIOREGENX, INC.
- filed_at: 2024-10-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007111/0001683168-24-007111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007111/bioregenx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-007111
- JSON: https://secwatch.observer/filing/0001683168-24-007111.json
- Plain text: https://secwatch.observer/filing/0001683168-24-007111.txt

## Key facts
- Executive change
  Richard Janney was appointed as Director at BIOREGENX, INC..
  - Action: appointed
  - Role: Director
  source text: On October 7, 2024, BioRegenx, Inc., a Nevada corporation (“BioRegenx”) appointed Richard Janney to serve as a member of its board of directors until his successor is elected and qualified, or until he resigns or is removed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007111/0001683168-24-007111-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.